Nerissa Kreher is Chief Medical Officer at Entrada Therapeutics, Inc. (TRDA). They have made 4 open-market trades across 2 companies since 2022, most recently 2026-07-01.
CIK 0001741850
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2025, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RZLT | BUY | 2025-06-13 | 2025-06-23 | $3.25 | $10K | +16.4% | +42.0% | +96.6% |
| TRDA | SELL · 10b5-1 | 2023-09-06 | 2023-09-06 | $13.47 | $12K | +2.9% | +6.7% | +0.9% |
| TRDA | SELL · 10b5-1 | 2023-08-02 | 2023-08-04 | $14.73 | $771K | +11.3% | +0.1% | +11.0% |
| TRDA | SELL · 10b5-1 | 2023-03-02 | 2023-03-03 | $10.56 | $17K | +25.4% | +40.0% | +5.4% |
| TRDA | SELL | 2022-12-30 | 2023-01-03 | $13.45 | $70K | -0.6% | -7.3% | +10.2% |
| TRDA | SELL | 2022-10-25 | 2022-10-27 | $21.27 | $537K | -11.7% | -35.2% | -36.2% |
| TRDA | SELL · 10b5-1 | 2022-09-26 | 2022-09-28 | $15.29 | $131K | -6.4% | +44.7% | -3.7% |
| TRDA | SELL | 2022-09-21 | 2022-09-23 | $15.08 | $115K | -11.3% | +24.6% | -2.7% |
| TRDA | SELL · 10b5-1 | 2022-09-15 | 2022-09-19 | $15.01 | $2K | +16.0% | +28.7% | +48.4% |
| TRDA | SELL · 10b5-1 | 2022-09-08 | 2022-09-12 | $15.11 | $31K | +9.3% | +18.1% | +32.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.